We have collected information about Alexza Molecular Delivery Corporation for you. Follow the links to find out details on Alexza Molecular Delivery Corporation.
Developing novel therapeutic treatments Alexza Pharmaceuticals is focused on the research, development, and commercialization of novel, proprietary products for the acute treatment of medical conditions. Alexza’s products and development pipeline are based on the Staccato® One Breath Technology™ – OBT™ system, a handheld inhaler designed to deliver a pure drug aerosol to the …
http://www.alexza.com/careers/
Alexza has innovative technology and talented people. Every individual plays a critical role in Alexza’s success. At Alexza, top engineers, scientists, clinical and product development experts, as well as our administrative staff work together with passion and drive to develop novel pharmaceutical products.
https://www.bloomberg.com/profile/company/33774Z:US
Alexza Molecular Delivery Corporation manufactures medical products. The Company offers research, development, and commercialization of proprietary products for the acute treatment of central ...
https://patents.justia.com/assignee/alexza-molecular-delivery-corporation
Abstract: Devices and methods of entraining a substance within an airflow are disclosed. Condensation aerosol delivery devices and methods of consistently producing multiple doses of a substance, such as a drug, having high purity, high yield, characterized by a particle size distribution appropriate for pulmonary delivery, and which can be administered to a user in a single dose are also ...
https://www.sbir.gov/sbc/alexza-molecular-delivery-corporation
DESCRIPTION (provided by applicant): Poor appetite is one of the subjective symptoms that cancer patients find most frustrating, and resulting cachexia is a common cause of death from cancer.
https://www.ventureradar.com/organisation/Alexza%20Pharmaceuticals/17f9bad9-0380-4e1c-a792-dfec50187bb3
"Alexza Molecular Delivery Corporation is developing its own products using the company’s Staccato™ drug delivery technology. This enables the rapid onset of therapeutic effect of many small molecule drugs as well as patient self-titration to the lowest effective dose to improve the treatment of acute and intermittent conditions.
https://www.sec.gov/Archives/edgar/data/1344413/000089161805000914/f15073orexv4w2.htm
This Second Amended And Restated Investors’ Rights Agreement (the “Agreement”) is made and entered into as of November 5, 2004 by and among Alexza Molecular Delivery Corporation, a Delaware corporation (the “Company”), the parties listed on the Schedule attached to this Agreement as Exhibit A and incorporated herein by reference (the “Schedule of Holders”) as investors (the ...
Searching for Alexza Molecular Delivery Corporation?
You can just click the links above. The data is collected for you.
